Journal article
When Is "type I" Ovarian Cancer Not "type I"? Indications of an Out-Dated Dichotomy
C Salazar, IG Campbell, KL Gorringe
Frontiers in Oncology | FRONTIERS MEDIA SA | Published : 2018
Abstract
The dualistic classification of epithelial ovarian cancer (EOC) into "type I" and "type II" is widely applied in the research setting; it is used as a convenient way of conceptualizing different mechanisms of tumorigenesis. However, this classification conflicts with recent molecular insights of the etiology of EOC. Molecular and cell of origin studies indicate that while type II tumors could be classed together, type I tumors are not homogenous, even within the histological types, and can have poor clinical outcomes. Type II high grade serous carcinoma and type I low grade serous carcinomas best fit the description of the dualistic model, with different precursors, and distinct molecular pr..
View full abstractGrants
Awarded by University of Melbourne
Funding Acknowledgements
This study was funded by the National Health and Medical Research Council of Australia APP1045783. CS was supported by a Melbourne University International Research Scholarship.